We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $156B
1-Year Est. Return 27.51%
This Fund
S&P 500
This Quarter Est. Return
+5.98%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.97%
AUM
$42B
AUM Growth
+$2.37B
Cap. Flow
-$349M
Cap. Flow %
-0.83%
Top 10 Hldgs %
5.64%
Holding
1,947
New
155
Increased
870
Reduced
686
Closed
148

Top Buys

Rank Stock Value
1
VFC icon
VF Corp
VFC
+$139M
2
HOLX
Hologic
HOLX
+$133M
3
CE icon
Celanese
CE
+$132M
4
AJG icon
Arthur J. Gallagher & Co
AJG
+$117M
5
ALL icon
Allstate
ALL
+$116M

Sector Composition

Rank Sector Weight
1 Financials 17.54%
2 Industrials 15.03%
3 Technology 14.81%
4 Consumer Discretionary 9.52%
5 Healthcare 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSTE icon
1701
Caesarstone
CSTE
$75.7M
$39K ﹤0.01%
1,068
-94,363
-99% -$3.04M
IMPV
1702
DELISTED
Imperva, Inc.
IMPV
$38K ﹤0.01%
925
HPP
1703
Hudson Pacific Properties
HPP
$795M
$34K ﹤0.01%
139
-365
-72% -$89.9K
IQV icon
1704
IQVIA
IQV
$38.2B
$32K ﹤0.01%
395
-12,801
-97% -$999K
SNCR
1705
DELISTED
Synchronoss Technologies
SNCR
$32K ﹤0.01%
144
IMMR icon
1706
Immersion
IMMR
$250M
$31K ﹤0.01%
3,615
PEB icon
1707
Pebblebrook Hotel Trust
PEB
$2.12B
$30K ﹤0.01%
1,015
-1,910
-65% -$55.4K
AXAS
1708
DELISTED
Abraxas Petroleum Corp
AXAS
$30K ﹤0.01%
736
CPT icon
1709
Camden Property Trust
CPT
$11.1B
$29K ﹤0.01%
360
-1,105
-75% -$90.9K
NWS icon
1710
News Corp Class B
NWS
$18.8B
$29K ﹤0.01%
2,179
-74
-3% -$954
LHO
1711
DELISTED
LaSalle Hotel Properties
LHO
$29K ﹤0.01%
1,000
-1,069,545
-100% -$31.8M
NBIX icon
1712
Neurocrine Biosciences
NBIX
$16.2B
$28K ﹤0.01%
649
-16,400
-96% -$703K
RARE icon
1713
Ultragenyx Pharmaceutical
RARE
$2.46B
$27K ﹤0.01%
400
+78
+24% +$5.94K
SKT icon
1714
Tanger
SKT
$4.59B
$26K ﹤0.01%
795
-1,520
-66% -$51.5K
ACFC
1715
DELISTED
Atlantic Coast Financial Corporation
ACFC
$26K ﹤0.01%
3,362
WOOF
1716
DELISTED
VCA Inc.
WOOF
$26K ﹤0.01%
284
-1,035,490
-100% -$92.9M
OHI icon
1717
Omega Healthcare
OHI
$14.7B
$25K ﹤0.01%
745
-1,430
-66% -$45.9K
ADMS
1718
DELISTED
Adamas Pharmaceuticals
ADMS
$25K ﹤0.01%
1,413
+351
+33% +$5.98K
TLGT
1719
DELISTED
Teligent, Inc
TLGT
$25K ﹤0.01%
326
+81
+33% +$5.84K
GRA
1720
DELISTED
W.R. Grace & Co.
GRA
$25K ﹤0.01%
357
-663,740
-100% -$46.6M
DQ
1721
Daqo New Energy
DQ
$893M
$24K ﹤0.01%
6,325
+295
+5% +$1.36K
JOYY
1722
JOYY Inc
JOYY
$3.77B
$24K ﹤0.01%
528
+25
+5% +$1.11K
MLNX
1723
DELISTED
Mellanox Technologies, Ltd.
MLNX
$24K ﹤0.01%
478
IONS icon
1724
Ionis Pharmaceuticals
IONS
$9.18B
$23K ﹤0.01%
581
+127
+28% +$5.7K
OMER icon
1725
Omeros
OMER
$929M
$23K ﹤0.01%
1,522

Similar funds

Victory Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Victory Capital Management held 1,947 positions worth $42B, up 6% from $39.6B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

Victory Capital Management's Q1 2017 filing shows 155 new, 870 increased, 686 reduced and 148 closed positions. Its largest new stake was Celanese: 1,512,133 shares worth $136M. The largest sale was Acuity Brands, an estimated $114M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Technology.

  • Victory Capital Management's largest Q1 2017 buy was Celanese: 1,512,133 shares worth $136M.
  • Victory Capital Management added most to VF Corp in Q1 2017, an estimated $139M increase.
  • Victory Capital Management's biggest Q1 2017 reduction was Acuity Brands, cutting an estimated $114M.
  • Victory Capital Management fully exited Mentor Graphics Corp in Q1 2017, selling an estimated $53.4M.
  • Victory Capital Management's ten largest holdings make up 5.6% of its $42B portfolio in Q1 2017.
  • Victory Capital Management opened 155 new positions and closed 148 in Q1 2017.
  • Victory Capital Management's portfolio value rose 6% quarter-over-quarter to $42B.

Based on Victory Capital Management's 13F filing for Q1 2017, filed 10 May 2017.